Renoprotective effects of chronic candesartan treatment in uninephrectomized rat

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 1, 2003, Pages 81-88

  Mozaffari, Mahmood S ^a   Patel, Kashyap B ^a   Schaffer, Stephen W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Candesartan; Diuresis; Glucose intolerance; Natriuresis; Uninephrectomy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN HEXETIL; DIURETIC AGENT; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROLYTE EXCRETION; EXTRACELLULAR FLUID; FLUID TRANSPORT; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; HEMODYNAMICS; HYPOTENSION; KALIURESIS; KIDNEY TUBULE ABSORPTION; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PLASMA VOLUME; PRIORITY JOURNAL; PROTEINURIA; RAT; SODIUM EXCRETION; UNINEPHRECTOMY; URINARY EXCRETION;

ANIMALS; BENZIMIDAZOLES; ELECTROLYTES; GLUCOSE INTOLERANCE; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0037214301     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200301000-00011     Document Type: Article

References (23)

1. Navar LG, Carmines PK, Huang WC, et al. The tubular effects of angiotensin II. Kidney Int 1987;31:S81-8.
2. Navar LG. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol 1998;274:F433-44.
3. 1 receptor blockade. Am J Hypertens 2000;13:45S-54S.
4. Weber MA. Interrupting the renin-angiotensin system: The role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension. Am J Hypertens 1999;12:189S-194S.
5. 1-receptor blockers. J Human Hypertension 1999;13(suppl 1):S11-20.
6. Burnier M, Roch-Ramel F, Brunner HR. Renal effects of angiotensin II receptor blockade in normotensive subjects. Kidney Int 1996;49:1787-90.
7. 1 receptor blockade by candesartan on arterial pressure and renal function in rats. Am J Physiol 1998;274:F940-5.
8. Noda M, Fukuda R, Matsuo T, et al. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int 1997;52(suppl 63):S-136-9.
9. Inada Y, Wada T, Shibouta Y, et al. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-{2′-(1H-tetrazol-5-yl) biphenyl-4-yl}methyl-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther 1994;268:1540-7.
10. 1 receptor antagonist candesartan in young spontaneously hypertensive rats. J Am Soc Nephrol 1999;10:S116-9.
11. Kawabata M, Takabatake T, Ohta H, et al. Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension. Blood Press Suppl 1994;5:117-21.
12. Christensen PK, Lund S, Parving HH. Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients. Kidney Int 2001;60:1435-42.
13. Mozaffari MS, Schaffer SW. Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. Kidney Int 2002;61:1750-9.
14. Knowler WC, Narayan KM, Hanson RL, et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-8.
15. Price DA, Porter LE, Gordon M, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999;10:2382-91.
16. Schaffer SW, Lombardini JB, Azuma J. Interaction between the actions of taurine and angiotensin II. Amino Acids 2000;18:305-18.
17. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992;72:101-63.
18. Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 2000;19:527-46.
19. Portha B, Blondel O, Serradas P, et al. The rat models of noninsulin-dependent diabetes induced by neonatal streptozocin. Diabetes Metab (Paris) 1989;15:61-75.
20. Schaffer SW, Mozaffari MS. The neonatal STZ model of diabetes. In: McNeil JH, ed. Experimental Models of Diabetes. Boca Raton: CRC Press; 1999:231-55.
21. Mozaffari MS, Wyss JM. Dietary NaCl-induced hypertension in uninephrectomized Wistar-Kyoto rats: Role of kidney function. J Cardiovasc Pharmacol 1999;33:814-21.
22. Baylis C, Brenner BM. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res 1978;43:889-98.
23. Weder AB. Sodium metabolism, hypertension, and diabetes. Am J Med Sci 1994;307(suppl 1):S53-9.